Tesla with sales decline + SAP maintains cloud growth rate and confirms outlook + Danaher's statements also drive Sartorius, Stedim and Evotec

Tesla $TSLA (-1.93%)with decline in sales

• Tesla recorded a nine percent drop in sales to 19.3 billion dollars and a 71 percent drop in profits to 409 million dollars in the past quarter.
• Analyst Dan Ives from Wedbush Securities estimates that Elon Musk's political activities could permanently reduce demand for Tesla by 15 to 20 percent.
• In its current quarterly report, Tesla refrains from its usual forecast of a return to growth.
• For the first time in its Q1 earnings report, Tesla does not mention when the company intends to return to growth.
• Tesla Inc. misses analysts' estimates of USD 0.42 with earnings per share of USD 0.27 in the first quarter. Revenue of USD 19.34 billion below expectations of USD 21.4 billion.
• Tech billionaire Elon Musk initiates withdrawal from Washington.
• From May, he will spend "considerably" less time in the government apparatus as President Donald Trump's cost-cutter, said the Tesla boss.
• Instead, he will focus more on the interests of the electric car manufacturer.

SAP $SAP (-1.94%)maintains cloud growth rate and confirms outlook

• SAP maintained its cloud growth in the first quarter and significantly increased its operating profit.
• The Walldorf-based software group confirmed its outlook for the current year.
• According to the DAX-listed company, the environment is characterized by high dynamics and uncertainty and further developments are difficult to predict.
• SAP is targeting currency-adjusted cloud growth of 26 to 28 percent to 21.6 to 21.9 billion euros this year.
• Cloud and software combined are expected to grow by 11 to 13 percent to 33.1 to 33.6 billion euros.
• The non-IFRS operating result is expected to reach EUR 10.3 to 10.6 billion after EUR 8.15 billion in 2024.
• In the first quarter, cloud revenue rose by 26% in constant currency to just under EUR 5 billion.
• Analysts had expected a consensus of EUR 5.06 billion from Visible Alpha.
• Currency-adjusted growth had already amounted to 26% in the fourth quarter.
• Non-IFRS operating profit rose by 58% to EUR 2.46 billion.
• The Current Cloud Backlog (CCB), which quantifies secured orders over the course of a year, rose by 29% to EUR 18.2 billion after adjusting for currency effects.
• The initial reaction of the share in after-hours trading in Germany was positive. They rose by more than 5 percent to 231 euros at the broker Lang & Schwarz.
• The SAP share had closed 3.32 percent lower at 218.50 euros on XETRA on Tuesday.
• SAP ADRs traded on the NYSE rose 6.48 percent to 268.75 US dollars in after-hours trading.

Danaher's $DHR (-0.72%)statements also drove Sartorius$SRT (+2%)Stedim $DIM (-0.17%)and Evotec $EVT (-1.21%)on

• The quarterly figures of the US pharmaceutical equipment manufacturer Danaher boosted the shares of Sartorius and its subsidiary Sartorius Stedim Biotech on Tuesday.
• The shares of pharmaceutical contract researcher Evotec also benefited.
• The reason for this was not only the better than expected results in the first quarter and the confirmation of the Group's annual targets.
• The fact that Danaher performed particularly well in the bioprocess technology segment, which is also an important pillar of the Göttingen-based Sartorius Group, probably put investors in a good mood.
• In addition, Danaher spoke of continued robust spending on research and development in the pharmaceutical sector.
• In the afternoon, the Sartorius preference share rose 5.9 percent to 221.30 euros at the top of the leading German Dax index and is thus back at its highest level since the end of March.
• The 21-day line, which signals the short-term trend, had already been overcome on Wednesday.
• The 50-day line as an indicator of the medium-term trend at just under EUR 226 and the long-term 200-day line at just over EUR 234 are now the next decisive resistances.
• The shares of French company Stedim Biotech recently rose by 3.9% to EUR 194.35 in Paris.
• In the MDax, the mid-cap index below the Dax, Evotec shares rose by 6.7 percent to 6.82 euros, while in the USA Danaher shares rose by 5.0 percent to 194.09 US dollars.
• Analyst Rachel Vatnsdal from the US bank JPMorgan spoke of Danaher "comfortably exceeding expectations" and "remarkable strength" in the bioprocessing sector.
• The bioprocessing division was the leader in the first quarter, she wrote.
• Compared to the previous quarter, orders there had increased significantly, while the company had also noted that it had not noticed any pull-forward effects in view of impending tariffs.
• According to stock market analysts, this should also have a positive effect on the industry as a whole.
• Like Sartorius, Danaher is broadly positioned in the healthcare sector with businesses in biotechnology and diagnostics.

Wednesday: Stock market dates, economic data, quarterly figures

• ex-dividend of individual stocks
• Lenzing EUR 3.00
• Heineken EUR 1.17
• Proximus EUR 0.10
• Adecco Group 1.00 CHF

• Quarterly figures / company dates USA / Asia
• 12:30 AT&T | GE Vernova | Boston Scientific quarterly figures
• 13:00 Philip Morris quarterly figures
• 13:30 Boeing quarterly figures
• 15:30 Goldman Sachs AGM
• 16:00 Cigna AGM
• 22:00 IBM | Texas Instruments | Lam Research
• 22:00 ResMed | Whirlpool quarterly figures
• No time specified: BYD quarterly figures

• Quarterly figures / Company dates Europe
• 07:30 Danone | Essilor-Luxottica 1Q sales
• 07:30 Volvo AB | Akzo Nobel quarterly figures
• 08:00 Reckitt Benckiser Trading Update 1Q
• 09:00 Just Eat Takeaway Trading Update 1Q
• 10:00 ASML | Sulzer Holding AGM
• 17:45 Kering quarterly figures

• Economic data

09:15 FR: Purchasing Managers' Index/PMI non-manufacturing | Purchasing Managers' Index/PMI manufacturing (1st release)

09:30 DE: Purchasing Managers' Index/PMI non-manufacturing (1st release) April PROGNOSE: 50.3 PREVIOUS: 50.9 Total Purchasing Managers' Index (1st release) PROGNOSE: 51.0 PREVIOUS: 51.3

09:30 DE: Purchasing Managers' Index/PMI manufacturing (1st release) April FORECAST: 47.6 PREVIOUS: 48.3

10:00 EU: Purchasing Managers' Index/PMI non-manufacturing Eurozone (1st release) April FORECAST: 50.5 PREVIOUS: 51.0

10:00 EU: Purchasing Managers' Index/PMI Manufacturing Eurozone (1st release) April FORECAST: 47.5 previously: 48.6 Total Purchasing Managers' Index (1st release) FORECAST: 50.4 previously: 50.9

10:30 UK: Purchasing Managers' Index/PMI non-manufacturing (1st release) Apri PROGNOSE: 51.6 previous: 52.5 | Purchasing Managers' Index/PMI manufacturing (1st release) April PROGNOSE: 44.2 previous: 44.9

11:00 EU: Trade Balance February

15:00 US: IMF, Fiscal Monitor

15:30 US: Fed St. Louis President Musalem and Fed Governor Waller, participate in Fed Listens Event

15:45 US: Purchasing Managers' Index/PMI Services (1st release) April Forecast: 52.8 Previous: 54.4 | Purchasing Managers' Index/PMI Manufacturing (1st release) April Forecast: 49.5 Previous: 50.2

16:00 US: New Home Sales March FORECAST: +1.3% yoy previous: +1.8% yoy

16:30 US: Crude oil inventories data (week) from the Energy Information Administration (EIA) previous week

18:00 US: Governing Council member Knot, speech at Peterson Institute conference

20:00 US: Fed, Beige Book

21:15 US: ECB Chief Economist Lane, participation in panel at IMF Spring Meetings

21:45 US: ECB Director Cipollone, participation in panel at IMF Spring Meetings

No time specified: CN: Auto Shanghai 2025 exhibition in Shanghai

FED warns of higher inflation + Luxury goods group Hermes grows less than expected + Siemens Energy targets record high + Evotec realigns itself + Chip manufacturer TSMC increases profits sharply

Fed Chairman Jerome Powell warns of higher inflation and slower growth due to Trump's tariff policy

• He emphasizes that the tariffs will probably lead to a temporary rise in inflation.
• The Federal Reserve's next interest rate decision is due in May, although it is widely expected to remain unchanged.
• Fed Chairman Jerome Powell warns that US government debt is on an unsustainable path and that this debt trajectory is a problem that needs to be addressed.
• Fed Chairman Powell explains that US economic growth is slowing, with moderate consumer growth and a wave of imports to avoid tariffs likely to weigh on GDP. According to Powell, the Fed intends to stick to the current rates for the time being until there is more clarity about the economic development.
• Fed Chairman Powell emphasizes that the role of the central bank is to ensure that tariffs only lead to a one-off price increase.
• Fed Chairman Jerome Powell sees immigration as an important reason for the strong economic growth in the USA in recent years.
• According to his speech to the Economic Club of Chicago, Fed Chairman Powell sees the US economy in a solid position despite increased uncertainty, with the labor market close to full employment and inflation above the 2 percent target.
• The Fed is well positioned to wait for more clarity before any potential adjustments to monetary policy as it continues to analyze incoming data, the evolving outlook and the balance of risks, he said.
• Fed Chairman Jerome Powell explains that the larger-than-expected tariffs so far are likely to lead to higher inflation and slower growth.
• US Federal Reserve Chairman Jerome Powell describes the US economy as 'solid' despite increased uncertainty and downside risks.
• Fed Chairman Jerome Powell believes the US central bank is in a good position to wait for further developments and gain more clarity for the time being.
• Fed Chairman Jerome Powell explains that the US Federal Reserve is well positioned and is currently waiting for more clarity.

Luxury goods group Hermes $RMS (-0.59%)grows less than expected

• The French luxury group Hermes continued to grow in the first quarter.
• However, the manufacturer of products such as Birkin and Kelly bags fell short of expectations.
• Turnover increased by 8.5 percent to 4.13 billion euros in the first three months of the year, as the EuroStoxx 50 heavyweight announced in Paris on Thursday.
• Adjusted for currency effects, growth amounted to 7.2 percent.
• Experts surveyed by Bloomberg had expected an increase of 7.9 percent.
• Business was particularly disappointing in Asia and the Pacific region, the Group's most important market.
• This makes Hermes the second major luxury goods manufacturer after LVMH to miss analysts' expectations.
• Hermes and LVMH are among the most valuable companies in Europe with a market capitalization of around 250 billion euros and 243 billion euros respectively.

Siemens Energy $ENR (-1%)take aim at record high - strong outlook

• A surprisingly good quarter and an optimistic outlook for the year as a whole boosted Siemens Energy shares on Maundy Thursday.
• Compared to the Xetra close on the previous day, they jumped 7.6 percent to 62.12 euros in pre-market trading on Tradegate.
• This would bring them closer to their record high of 64.56 euros reached in mid-February in Xetra trading.
• The energy technology group's outlook is very strong and clearly better than expected, praised one trader.
• The market consensus is now likely to rise by double digits, wrote analyst Akash Gupta from JPMorgan.

Evotec $EVT (-1.21%)realigns itself - wants to accelerate growth

• The pharmaceutical drug researcher and developer Evotec is realigning itself.
• According to a statement on Thursday, the company intends to focus on high-value services and therapeutic areas in future and reduce its project portfolio by around 30 percent.
• The company intends to withdraw from investments and focus on the two pillars of drug discovery & preclinical development and the Just - Evotec Biologics division in future, it said. In addition to the current cost program, the company plans to save more than EUR 50 million by 2028.
• Between 2024 and 2028, Evotec is targeting an average annual growth rate of eight to 12 percent.
• The margin on earnings before interest, taxes, depreciation and amortization (EBITDA) adjusted for exceptional effects is expected to reach more than 20 percent.
• In the past year 2024, turnover rose by 2% to EUR 797 million in a difficult market environment.
• Adjusted Group EBITDA fell from 66.4 million to 22.6 million euros.
• In the new year, turnover is expected to increase more strongly again, by around five to ten percent to between 840 and 880 million euros.
• Adjusted EBITDA is expected to improve to between 30 and 50 million euros.

Chip manufacturer TSMC $TSM (-0.93%)increases profit strongly

• Demand for AI servers and smartphones as well as pull-forward effects before US tariffs came into force have boosted the profits of Taiwanese chip manufacturer TSMC in the first quarter.
• The surplus rose by a good 60 percent year-on-year to 362 billion Taiwan dollars (9.8 billion euros), as the world's largest chip contract manufacturer announced on Thursday.
• This is slightly more than analysts had expected.
• As already announced, TSMC increased its turnover by almost 42 percent to 839 billion Taiwan dollars.
• This is the strongest growth since 2022.
• Electronics manufacturers had stocked up on goods in US warehouses in anticipation of trade and shipping disruptions.
• The international trade disputes triggered by the US had recently weighed on sentiment in the industry.
• Recently, however, the US government exempted smartphones, laptops and other important electronics from special tariffs against numerous countries, including China.
• This is a relief for American suppliers of computer technology, most of whose devices are manufactured in Asia.
• It is also positive for US companies that are expanding their data centers for artificial intelligence.
• The devices are mainly built outside the USA by US companies such as Dell, using chips from the Californian company Nvidia, which come from Taiwan.
• Much of the technology was already less affected because many of the servers are assembled in Mexico and fell under exemptions for trade agreements.
• In addition, chip companies such as Intel and TSMC are currently in the process of expanding their production in the USA with new factories.
• It was only at the beginning of March that TSMC announced investments of 100 billion dollars in the coming years.
• However, there are now increasing signs that investment in data centers and AI chips could slow down somewhat.
• Microsoft, for example, has scaled back projects worldwide.
• Some analysts have recently warned that TSMC may have to lower its sales target for the current year in view of the global uncertainty and the potential economic consequences.
• To date, the company has expected sales growth in the mid-20 percent range.
• The company's outlook for the second quarter could now possibly alleviate these fears to some extent.
• According to information released on Thursday, TSMC expects sales of 28.4 to 29.2 billion US dollars for the second quarter of the year.
• This is more than the 27.2 billion US dollars expected by analysts on average.

Thursday: Stock market dates, economic data, quarterly figures

Small expiry day | Stock exchange holiday in Oslo, Copenhagen | Stock exchange trading shortened in Stockholm

• ex-dividend of individual stocks
• PostNL EUR 0.04

• Quarterly figures / company dates USA / Asia
• 07:30 Taiwan Semiconductor quarterly figures
• 11:55 Unitedhealth Group quarterly figures
• 13:00 American Express | Blackstone quarterly figures
• 13:30 State Street | Ally Financial quarterly figures
• 22:00 Netflix quarterly figures

• Quarterly figures / Company dates Europe
• 07:00 ABB Ltd | Evotec | Hamborner Reit Annual Report
• 08:00 Hermes International quarterly figures
• 09:00 Pernod-Ricard 3Q sales
• 10:30 Beiersdorf AGM
• 14:00 Evotec analyst and press conference
• 18:00 L'Oreal 1Q sales
• 18:30 L'Oreal analyst conference

• Economic data

08:00 DE: Manufacturing orders on hand and backlog February | Producer prices March FORECAST: -0.1% yoy/+0.3% yoy previous: -0.2% yoy/+0.7% yoy

08:00 DE: Building permits February | Hospitality sales February

08:00 CH: Trade Balance March

14:15 EU: ECB, outcome of the Governing Council meeting Deposit rate FORECAST: 2.25% previously: 2.50%

14:30 US: Housing Starts/Permits March Housing Starts FORECAST: -6.1% yoy previous: +11.2% yoy Building Permits FORECAST: -1.1% yoy previous: -1.2% yoy

14:30 US: Initial jobless claims (week) PROGNOSE: 225,000 previous: 223,000 | Philadelphia Fed Index April PROGNOSE: 3.5 previous: 12.5

ECB, PK after Governing Council meeting

16:00 US: IMF chief Georgieva, opening speech at the spring meeting of the IMF and World Bank

No time specified:

- US: Japan's Economy Minister Akazawa meets US Treasury Secretary Bessent and Trade Representative Greer

- US: US President Trump receives Italian Prime Minister Meloni at the White House

- MY: China's President Xi, state visit to Malaysia

Netflix with record increase of almost 19 million users + Evotec receives funding from the Korean government + Trump announces AI infrastructure investments + Trump open to Musk's purchase of Tiktok

Netflix $NFLX (-0.99%)delivers after-hours figures

• Netflix has broken the 300 million user mark after record growth in the past quarter.
• In the quarter with the second season of the South Korean hit series "Squid Game", the company added almost 19 million users, as announced by the company on Tuesday after the US stock exchange closed.
• This was around twice as many as analysts had expected - the video streaming market leader also exceeded Wall Street forecasts for revenue and profit.
• Netflix now has 301.6 million customer households.
• The largest quarterly increase to date was around 15 million at the start of the coronavirus pandemic in 2020.
• However, with the record, Netflix will now stop providing information on the number of users.
• Netflix's revenue rose by 16% year-on-year to 10.2 billion dollars in the past quarter.
• At the bottom line, profit jumped from 938 million dollars a year earlier to 1.87 billion dollars.
• The results were well received by investors: The share price rose by eight percent at times in after-hours trading.

Evotec $EVT (-1.21%)receives funding from the Korean government to develop novel antibody-based treatments for lung diseases

• Yonsei University, Zymedi and Evotec receive USD 4.5 m from the Korea Institute of Advanced Technology under the Korean Ministry of Trade, Industry and Energy.
• The funding will support a novel collaboration to develop first-in-class therapeutics for the treatment of asthma and idiopathic pulmonary fibrosis

Trump announces AI infrastructure investments led by Oracle $ORCL (-1.6%), OpenAI and Softbank $9984 (+0.12%)supported by

• Executives pledged to invest an initial $100 billion and up to $500 billion over the next four years in the project, which will be set up as an independent company
• https://www.cnbc.com/2025/01/21/trump-ai-openai-oracle-softbank.html?irclickid=x7cRozR4exyKT%3ARS-WUlu0FFUksxGHydHx9a1w0&irgwc=1

Trump open to Musk's purchase of Tiktok

• US President Donald Trump has no objections to tech billionaire Elon Musk taking over Tiktok.
• He is open to it if Musk wants to buy the video app, Trump said in the White House in response to a question from journalists.
• He also reiterated that he believes Tiktok should be half-owned by the USA.
• Musk's name had recently been mentioned in media reports.
• The Wall Street Journal and the financial service Bloomberg wrote that the Chinese government was considering the option of selling Tiktok to Musk.
• The tech billionaire and current Trump confidant has considerable business interests in China: the electric car manufacturer Tesla, which he manages, has a large plant in Shanghai.
• Musk could link Tiktok with X Musk already owns the online platform X, which is based on the short messaging service he bought, Twitter.
• He supported Trump's election campaign with more than 200 million dollars and made X an even more important platform for the president and his supporters.
• The clock is ticking for Tiktok in the USA. A US law stipulated that the China-based Tiktok owner Bytedance had to divest itself of Tiktok by last Sunday in order for the app to remain available in the US.
• However, this did not happen and the app was temporarily taken offline at the weekend.
• Trump gives Tiktok more time On Monday, however, Trump issued an executive order that the Department of Justice should not enforce the provisions of the law for 75 days.
• It remains to be seen whether he can do this legally.
• Trump is convinced that he can strike a deal for Tiktok. He argues that Tiktok is worth nothing without the US market and that he is therefore in a strong negotiating position.
• Officially, Tiktok has always rejected a change of ownership.
• Concerns in the US The law - which Trump must also abide by - was triggered by worries that the Chinese government could use Tiktok to gain access to US users' data and manipulate public opinion in the US.
• Tiktok rejects this.
• At the same time, Trump played down the data protection concerns.
• There are bigger problems than information about young Tiktok users falling into Chinese hands, he said on Monday.

Wednesday: Stock market dates, economic data, quarterly figures

• ex-dividend of individual stocks
• Acerinox EUR 0.31
• Dell Technologies Registered USD 0.45

• Quarterly figures / company dates USA / Asia
• 12:25 Johnson & Johnson quarterly figures
• 12:30 GE Vernova quarterly figures
• 12:45 Halliburton | Johnson & Johnson quarterly figures
• 12:55 Procter & Gamble quarterly figures
• 13:00 Travelers Cos quarterly figures
• 13:30 Abbott Laboratories quarterly figures
• 16:00 United Airlines quarterly figures
• 22:10 Alcoa annual results

• Quarterly figures / Company dates Europe
• 08:00 Easyjet quarterly figures
• 17:45 VW Pre Close Call

Economic data

11:00 EU: Government Debt 3Q | Government Deficit 3Q

12:00 DE: Bundesbank, monthly report January

16:00 US: Leading Indicators Index December FORECAST: -0.1% yoy previous: +0.3% yoy

16:15 CH: ECB President Lagarde, participation in dialog on "Beyond Crisis: Unlocking Europe's Potential" at World Economic Forum Davos

19:30 CH: ECB Governing Council member Nagel, participation in panel at World Economic Forum Davos

19:30 DE: President of the Deutsche Bundesbank, Joachim Nagel, participates in a panel discussion at the event "Evening Reception, Frankfurt RheinMain International Marketing of the Region"

My strategy:

$VWCE (-0.74%) I save this monthly with 200€. I also make purchases when I have a lot of cash, such as last month (500€)

$BTC (-1.65%) Bitcoin I save weekly with 12,50€ (50€ monthly) plus single purchases if I think the price is reasonable.

The other two shares were from earlier for playing namely$EVT (-1.21%) c $SYNT but I will sell them as soon as I break even.

I would like to increase my savings plans so that I reach €20,000 by the time I am 18.

What have I learned?

"You're weird" and different from others your age, which means you have less contact with people your own age. This makes you lonelier if you don't have anyone with similar interests.

It's not enough to read the book the book or that book (I read a lot for a long time, I wasn't the biggest fan, but for my reading and writing weakness, there's an advantage to being stuck and learning things). or to chase after that and the new investment strategy. The fact is, the biggest driver of your wealth is what you put money into.

You need a business or a job that you can scale or at least get money out of (I have built a window cleaning business with 32 clients).

Hold on to your dreams and always finish what you start. I'm currently in a phase where I don't have anyone outside of me and my family. That means I have endless time for myself. I don't really have any excuses for not following through with my habits and the like. 2.3 of my habits are always taking a shower, taking a cold shower, doing at least 30 pull-ups, 30 dips, 60 push-ups every day and reading every day.

Habits forget a day, if not several days. What have I learned? In two years of trying to "pull through" I have realized one thing in particular, even if sometimes you haven't done your H Habits for a week or even a month, you have to keep at it and pick it up again sooner or later.

Goals: In the short term, €20,000 by the time I'm 18.

Long term: financial independence and live happily

Changes at Deutsche Börse:

The used car dealer Auto1 $AG1 (-2.49%) and the biotech company Evotec $EVT (-1.21%) return to the small cap index on 23.12.24 MDax of the German Stock Exchange. They will replace the metal recycler Befesa $BFSA (-0.58%) and the automotive and industrial supplier Stabilus $STM (-0.66%) which will be relegated to the small-cap index SDax, as announced by Deutsche Börse subsidiary ISS Stoxx on Wednesday evening.

Evotec was only forced to leave the MDax in September, but since then the shares have risen again in view of a possible sale of the company. Auto1, on the other hand, was previously listed on the MDax until spring 2022.

In addition, the SDAX also has three newcomers. The software company Nexus $NXU (+0%) the scientific publisher Springer Nature
$SPG (-1.36%) and the biosimilars specialist Formycon $FYB (-1.42%) .

On the other hand, the telecom equipment supplier Adtran Holdings
$ADTN (-3.04%) the office furniture mail order company Takkt
$TTK (-0.53%) and the hydrogen specialist Thyssenkrupp Nucera
$NCH2 (-1.42%) .

In the DAX there are no changes.

The changes will take effect on December 23 of this year.

Handelsblatt

05.12.2024

Bitcoin breaks through $100,000 + JPMorgan upgrades SAP to 'Overweight' + Jefferies raises Hellofresh to 'Buy' with target up to EUR 16.50 + Auto1 and Evotec return to MDax

Bitcoin $BTC (-1.65%)jumped above $100,000 during the night

• The $100,000 mark has been a mark that has been eagerly awaited in the crypto scene for years.
• Tonight, Bitcoin briefly jumped to $104,000.
• Now, of course, everyone is waiting to see what happens next. Will the journey continue or will the correction come now? What do you think?

JPMorgan sees SAP $SAP (-1.94%)as the favorite for 2025

• The US bank JPMorgan has left its rating for SAP at "Overweight" with a target price of 260 euros.
• Analyst Toby Ogg maintains his preference for SAP and Sage in his 2025 outlook for the software and IT industry, which was published on Wednesday.
• Both shares are also on the "Analyst Focus List".
• SAP's sales growth is likely to accelerate until 2028.

Jefferies raises Hellofresh $HFG (+1.76%)to 'Buy' - target raised to 16.50 euros

• The analyst firm Jefferies has more than doubled its price target for Hellofresh shares from 7.50 to 16.50 euros and upgraded the shares from "Hold" to "Buy".
• The cooking box mail order company is ending two difficult years with a new focus on operating profit and cash flow, wrote analyst Giles Thorne in his buy recommendation published on Thursday.
• These plans are underpinned by stabilized box sales and growth in the newer ready-to-eat segment.
• In addition, there are still opportunities for optimization.

Auto1 $AG1 (-2.49%)and Evotec $EVT (-1.21%)return to MDax - No changes in the Dax

• Hamburg-based Evotec was only forced to leave the MDax in September, but since then the shares have risen again in view of a possible sale of the company.
• Auto1 was already a member of the MDax until spring 2022.
• As expected, there are no changes in the leading Dax index of the 40 heaviest stocks.
• Three companies are moving up to the SDax: The software company Nexus is benefiting from a takeover bid worth around 1.1 billion euros from financial investor TA Associates, which caused its shares to rise sharply.
• The scientific publisher Springer Nature made the leap just over two months after its IPO.
• The changes will take effect on December 23, one day before Christmas Eve.

https://www.handelsblatt.com/finanzen/maerkte/marktberichte/maerkte-live-auto1-und-evotec-kehren-in-mdax-zurueck-keine-aenderungen-im-dax-/30026990.html

Thursday: Stock market dates, economic data, quarterly figures

• ex-dividend of individual stocks

Qualcomm USD 0.85

• Quarterly figures / company dates USA / Asia

22:05 Hewlett Packard Enterprise Annual results

• Quarterly figures / company dates Europe

07:00 Aurubis detailed annual results and annual report

10:00 Merck KGaA: Media event "Artificial Intelligence at Merck"

11:00 KWS Saat AGM

14:00 Aurubis Analyst Conference | Safran Capital Markets Day

No time specified: Fuchs SE Capital Markets Day

• Economic data

08:00 DE: New orders October seasonally adjusted FORECAST: -2.0% yoy previous: +4.2% yoy

11:00 EU: Retail Sales October Eurozone FORECAST: -0.3% yoy previous: +0.5% yoy

14:30 US: Initial jobless claims (week) FORECAST: 215,000 Previous: 213,000

14:30 US: Trade Balance October FORECAST: -74.80 bn USD previously: -84.36 bn USD

22.11.2024

Snowflake rises up to 25% + Bitcoin almost at $100,000 + Rotation in MDax + Carl Zeiss Meditec falls to low since 2018 + Berenberg rates CTS Eventim a 'Buy' - target 100 euros

The Snowflake $SNOW (-2.16%) shares rose 25% after the data analytics provider raised its full-year product revenue guidance and announced that it has partnered with AI company Anthropic to expand its cloud services.

The Bitcoin $BTC (-1.65%) reached just under $100,000 overnight and currently stands at $99,000.

What do you think, will Bitcoin reach $100,000 in November, or even today?

The US bank JPMorgan expects only a few changes for the next index review by Deutsche Börse at the beginning of December. While everything should remain the same in the leading Dax index, analyst Pankaj Gupta expects a swap in the mid-cap index below it, the MDax, where, according to him, industrial recycler Befesa will probably make way for drug researcher Evotec $EVT (-1.21%) will have to give way. Befesa $BFSA (-0.58%) would be relegated to the SDax, the index of smaller stocks. In the TecDax, Gupta expects that SMA Solar $S92 (-0.24%) will make way for the internet service provider Ionos $IOS (+0.53%) Deutsche Börse will review the indices of the Dax family (Dax, MDax, SDax and TecDax) on Wednesday, December 4, and announce any changes after the close of trading in the US. The changes will come into effect on Monday, December 23.

The downturn in the share price of Carl Zeiss Meditec $AFX (-0.21%) continued on Thursday with a new six-year low. The trend at the medical technology manufacturer has been pointing downwards since 2021, and this trend has intensified in the current year since March. At that time, the shares were still trading above 123 euros. On Thursday, the drop of over four percent pushed them down to 54.45 euros. This marks the lowest level since April 2018. With brief exceptions in August and late October and early September, the shares have been trading below the 200-day line, which is a popular long-term indicator for chart-oriented investors, for months. Jack Reynolds-Clark from RBC Research did not paint a good picture for the company at the beginning of November, downgrading it to "Sector Perform" due to uncertain demand in the various end markets. He emphasized that the consensus for 2025 depicts a rather optimistic scenario that is difficult to justify.

The private bank Berenberg has raised its rating for CTS Eventim $EVD (+1.01%) to "Buy" with a target price of 100 euros. The event organizer presented mixed quarterly figures, wrote analyst Gerhard Orgonas on Thursday evening. He cut his earnings estimates until 2026, taking into account integration costs and a slightly lower ticketing margin.

• CTS Eventim increased its consolidated revenue by 15.8 percent to EUR 2.027 billion in the first nine months of 2024. Adjusted EBITDA grows by 12.1 percent to EUR 322.7 million in the same period. The company's management is sticking to its forecast and expects a significantly higher Adjusted EBITDA for the full year compared to the previous year.
• CTS Eventim records a 22.9 percent increase in revenue to EUR 564.6 million in the Ticketing segment and a 13.6 percent increase to EUR 1.494 billion in the Live Entertainment segment. The company is also awarded the contract for the construction and operation of a new large arena by Wien Holding.

Friday: Stock market dates, economic data, quarterly figures

ex-dividend of individual stocks

Schloss Wachenheim EUR 0.60

Cummins Inc. USD 1.82

CRH 0.35 GBP

Quarterly figures / company dates Europe

No time specified: Vinci Investor Day | Unilever Capital Markets Day

Economic data

• 08:00 DE: GDP (2nd release) 3Q calendar and seasonally adjusted yoy FORECAST: +0.2% yoy 1st release: +0.2% yoy 2nd quarter: -0.3% yoy calendar-adjusted yoy FORECAST: -0.2% yoy 1st release: -0.2% yoy 2nd quarter: -0.3% yoy
• 09:15 FR: Purchasing Managers' Index/PMI non-manufacturing (1st release) November FORECAST: 49.0 PREV: 49.2 Total Purchasing Managers' Index (1st release) FORECAST: 48.1 PREV: 48.1
• 09:15 FR: Purchasing Managers' Index/PMI manufacturing (1st release) November FORECAST: 44.0 PREVIOUS: 44.5
• 09:30 DE: Purchasing Managers' Index/PMI non-manufacturing (1st release) November PROGNOSE: 51.8 PREVIOUS: 51.6 Total Purchasing Managers' Index (1st release) PROGNOSE: 48.3 PREVIOUS: 48.6
• 09:30 DE: Purchasing Managers' Index/PMI manufacturing (1st release) November FORECAST: 43.0 PREVIOUS: 43.0
• 10:00 EU: Purchasing Managers' Index/PMI non-manufacturing Eurozone (1st release) November FORECAST: 51.5 previously: 51.6
• 10:00 EU: Purchasing Managers' Index/PMI manufacturing Eurozone (1st release) November PROGNOSE: 46.0 PREVIOUS: 46.0 Total Purchasing Managers' Index (1st release) PROGNOSE: 49.8 PREVIOUS: 50.0
• 10:30 UK: Purchasing Managers' Index/PMI non-manufacturing (1st release) November FORECAST: 52.0 PREVIOUS: 52.0
• 10:30 UK: Purchasing Managers' Index/PMI Manufacturing (1st release) November FORECAST: 50.0 PREVIOUS: 49.9
• 15:45 US: Purchasing Managers' Index/PMI Services (1st release) November FORECAST: 55.0 PREVIOUS: 55.0
• 15:45 US: Purchasing Managers' Index/PMI Manufacturing (1st release) November FORECAST: 48.8 PREVIOUS: 48.5
• 16:00 US: Consumer Sentiment Index Uni Michigan (2nd survey) November FORECAST: 73.5 1st survey: 73.0 previous: 70.5

15.11.2024

Amazon competes with Temu and Shein with low prices + Burberry share price jumps after quarterly figures + Another damper - takeover rally at Evotec + UBS raises target for Delivery Hero to 56 euros - 'Buy'

Amazon $AMZN (-1.28%) no longer wants to let Chinese competitors such as Temu or the Singaporean retailer Shein take the butter off its bread in the low-price segment and is therefore launching the new Amazon Haul store, which is intended to attract buyers with particularly low prices. The launch is initially taking place as a beta in the USA.

https://www.computerbase.de/news/wirtschaft/amazon-haul-amazon-macht-temu-und-shein-mit-billigpreisen-konkurrenz.90292/

The shares of Burberry $BRBY (-3.46%) have reacted to the quarterly figures and the British luxury clothing manufacturer's new business strategy with a jump in the share price. In the late morning, the shares were up 15 percent at 841 pence. The loss was smaller than feared, UBS analyst Zuzanna Pusz said in an initial reaction. The new CEO Joshua Schulman wants to refocus on the origins of the Burberry brand before expanding into other areas, commented analyst Aarin Chiekrie from asset manager Hargreaves Lansdown. He is unlikely to want to make the same mistake as his predecessors by targeting Burberry's offering at a narrow base of luxury customers at the expense of a loyal fan base. With Thursday's jump in the share price, the shares continued their recent recovery, having cost less than 600 pence towards the end of September. At the start of 2024, it had been more than 1,400 pence. However, many luxury goods stocks then came under pressure, partly due to weakening demand in the important Chinese market.

Investors are focusing on Evotec $EVT (-1.21%) takeover fantasy, which had already emerged at the beginning of the week. The US company Halozyme Therapeutics is reportedly targeting the Hamburg-based drug researcher. The price offered is EUR 11 per share in cash. Evotec shares soared to 10.80 euros in pre-market trading, gaining around a quarter compared to the Xetra close. However, this is little consolation for investors, as they had started the year at over 21 euros. In initial reactions, analysts emphasized the high intrinsic value, which is now crystallizing somewhat better.

The major Swiss bank UBS has raised the price target for Delivery Hero $DHER (-0.6%) from 47 to 56 euros and left the rating at "Buy". The potential Talabat IPO puts the true value of the group in the spotlight, analyst Jo Barnet-Lamb wrote in his commentary on Friday. Such value creation could also pave the way for distributions to shareholders. Delivery Hero remains a one-year UBS favorite in the European internet sector.

Friday: Stock market dates, economic data, quarterly figures

ex-dividend of individual stocks

Shell USD 0.69

Starbucks 0.61 USD

Corning 0.28 USD

Whirlpool USD 1.75

Quarterly figures / company dates USA / Asia

05:00 Lenovo quarterly figures

13:30 Alibaba quarterly figures

Quarterly figures / Company dates Europe

07:30 Assicurazioni Generali | Vallourec Quarterly figures

Untimed: AstraZeneca Investor Day

Economic data

02:30 CN: Retail sales October FORECAST: +3.7% yoy previous: +3.2% yoy

03:00 CN: Industrial production October FORECAST: +5.6% yoy previously: +5.4% yoy

08:00 UK: GDP (1st release) 3Q PROGNOSE: +0.2% yoy/+1.0% yoy Q2: +0.5% yoy/+0.7% yoy | GDP month September PROGNOSE: +0.1% yoy | Industrial production September PROGNOSE: 0.0% yoy/-1.2% yoy previous: +0.5% yoy/-1.6% yoy

14:30 US: Retail Sales October PROGNOSE: +0.3% yoy previous: +0.4% yoy Retail Sales ex Motor Vehicles PROGNOSE: +0.3% yoy previous: +0.5% yoy

14:30 US: Empire State Manufacturing Index November FORECAST: 0.0 previous: -11.9

14:30 US: Import and Export Prices October Import Prices PROGNOSE: -0.1% yoy previous: -0.4% yoy

15:15 US: Industrial Production and Capacity Utilization October Industrial Production PROGNOSE: -0.2% yoy previous: -0.3% yoy Capacity utilization PROGNOSE: 77.3% previous: 77.5%

16:00 US: Inventories September PROGNOSE: +0.2% yoy previous: +0.3% yoy

Evotec $EVT (-1.21%) saw its share price rise sharply today after reports emerged of a possible takeover by a US pharmaceutical group. $HALO (-0.81%) have emerged. This news has caused the share price of the Hamburg-based biotechnology company, which specializes in drug discovery and development, to rise sharply. Analysts and investors are speculating about the strategic advantages such a deal could bring for both sides, particularly in a growing market for innovative drug research.

Personal opinion:

Should the takeover actually take place it would be a win-win situation for investors in both companies, as Evotec certainly has exciting projects underway.

Source:

https://www.t-online.de/finanzen/boerse/ticker/aktie-im-fokus-evotec-springen-hoch-moegliche-uebernahme/0DB2DE00629B99CE/

The news is based on what I personally consider to be reputable sources. However, I do not guarantee their accuracy. No advice.